Guruli G - Search Results

1

A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.

Daniel R, Wu Q, Williams V, Clark G, Guruli G, Zehner Z. Daniel R, et al. Among authors: guruli g. Int J Mol Sci. 2017 Jun 16;18(6):1281. doi: 10.3390/ijms18061281. Int J Mol Sci. 2017. PMID: 28621736 Free PMC article.

2

Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model.

Sulek JE, Robinson SP, Petrossian AA, Zhou S, Goliadze E, Manjili MH, Toor A, Guruli G. Sulek JE, et al. Among authors: guruli g. Prostate. 2017 Mar;77(4):361-373. doi: 10.1002/pros.23275. Epub 2016 Nov 8. Prostate. 2017. PMID: 27862100

3

MODULATION OF ANTITUMOR IMMUNE RESPONSE IN MOUSE PROSTATE CANCER MODEL.

Mitskevich N, Tsertsvadze T, Mchedlishvili K, Matchavariani K, Guruli G. Mitskevich N, et al. Among authors: guruli g. Georgian Med News. 2017 May;(266):39-47. Georgian Med News. 2017. PMID: 28628013

4

Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.

Marchioni M, Primiceri G, Cindolo L, Hampton LJ, Grob MB, Guruli G, Schips L, Shariat SF, Autorino R. Marchioni M, et al. Among authors: guruli g. BJU Int. 2017 Sep;120(3):313-319. doi: 10.1111/bju.13935. Epub 2017 Jul 19. BJU Int. 2017. PMID: 28621055 Review.

5

Dendritic cell trafficking in tumor-bearing mice.

Krzastek SC, Goliadze E, Zhou S, Petrossian A, Youniss F, Sundaresan G, Wang L, Zweit J, Guruli G. Krzastek SC, et al. Among authors: guruli g. Cancer Immunol Immunother. 2018 Dec;67(12):1939-1947. doi: 10.1007/s00262-018-2187-z. Epub 2018 Jun 25. Cancer Immunol Immunother. 2018. PMID: 29943070 Free PMC article.

6

Endothelin-1 inhibits apoptosis in prostate cancer.

Nelson JB, Udan MS, Guruli G, Pflug BR. Nelson JB, et al. Among authors: guruli g. Neoplasia. 2005 Jul;7(7):631-7. doi: 10.1593/neo.04787. Neoplasia. 2005. PMID: 16026642 Free PMC article.

7

Conditioning neoadjuvant therapies for improved immunotherapy of cancer.

Benson Z, Manjili SH, Habibi M, Guruli G, Toor AA, Payne KK, Manjili MH. Benson Z, et al. Among authors: guruli g. Biochem Pharmacol. 2017 Dec 1;145:12-17. doi: 10.1016/j.bcp.2017.08.007. Epub 2017 Aug 10. Biochem Pharmacol. 2017. PMID: 28803721 Free PMC article. Review.

8

Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets.

Aqbi HF, Coleman C, Zarei M, Manjili SH, Graham L, Koblinski J, Guo C, Xie Y, Guruli G, Bear HD, Idowu MO, Habibi M, Wang XY, Manjili MH. Aqbi HF, et al. Among authors: guruli g. Breast Cancer Res. 2020 Oct 28;22(1):116. doi: 10.1186/s13058-020-01357-9. Breast Cancer Res. 2020. PMID: 33115528 Free PMC article.

9

Establishment of a new robotic prostatectomy program at a tertiary Veteran's Affairs medical center.

Moore BW, Dolat ME, McPartlin D, Mayer Grob B, Guruli G, Hampton LJ. Moore BW, et al. Among authors: guruli g. J Robot Surg. 2013 Jun;7(2):171-5. doi: 10.1007/s11701-012-0364-1. Epub 2012 Jun 27. J Robot Surg. 2013. PMID: 27000909

10

Immunotherapy of cancer: targeting cancer during active disease or during dormancy?

Shah SA, Zarei M, Manjili SH, Guruli G, Wang XY, Manjili MH. Shah SA, et al. Among authors: guruli g. Immunotherapy. 2017 Sep;9(11):943-949. doi: 10.2217/imt-2017-0044. Immunotherapy. 2017. PMID: 29338608 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page